75N99224R00001: Antigens Predicted for Broad Viral Efficacy through Computational Experimentation (APECx)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Advanced Research Projects Agency for Health notices from 2023.
Advanced Research Projects Agency for Health offered grants to any type of organization. Applications closed on February 16, 2024.
From the official notice on Grants.gov, last changed November 21, 2023. Checked November 7, 2026.
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | November 21, 2023 |
|---|---|
| Deadline | February 16, 2024 |
| Archived by Grants.gov | February 18, 2024 |
Who can apply
This opportunity was open to any type of organization.
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Please see BAA for eligibility information.
Is this a realistic fit?
- Most of the program's money (96% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
The Advanced Research Projects Agency for Health (ARPA-H) posts this funding opportunity in support of its Antigens Predicted for Broad Viral Efficacy through Computational Experimentation (APECx) Program. ARPA-H anticipates multiple awards and award types will result from this announcement. Interested parties are invited to review attached APECx Research & Development Solicitation No. 75N99224R00001. Abstracts are due December 15, 2023, 9:00 AM ET. Proposals will be invite-only and will be due February 16, 2024, 5:00 PM ET. An abstract must be submitted to be invited to submit a proposal. Please ensure to follow this opportunity for any updates. For more information about APECx, please visit https://arpa-h.gov/engage/programs/apecx/. Please note that the APEX Accelerators government contracting resource for small businesses notice is included on all SAM.gov postings and is unrelated to the ARPA-H APECx program.
Who has won ADVANCED RESEARCH PROJECTS AGENCY for HEALTH (ARPA-H) grants before
From fiscal 2021 to 2025, ADVANCED RESEARCH PROJECTS AGENCY for HEALTH (ARPA-H) (93.384) awarded $524 million across 42 grant awards, an average of $12.5 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Regents of the University of California, San Francisco | California | 3 | $51.9 million |
| Vanderbilt University Medical Center | Tennessee | 2 | $39.8 million |
| University of Washington | Washington | 2 | $38.9 million |
| William Marsh Rice University | Texas | 2 | $35.4 million |
| Emory University | Georgia | 2 | $33.7 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is 75N99224R00001 still open?
No. It closed on February 16, 2024.
Who can apply for Antigens Predicted for Broad Viral Efficacy through Computational Experimentation (APECx)?
Advanced Research Projects Agency for Health accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for Antigens Predicted for Broad Viral Efficacy through Computational Experimentation (APECx)?
Closed February 16, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has won ADVANCED RESEARCH PROJECTS AGENCY for HEALTH (ARPA-H) grants before?
The largest recipients over five fiscal years were The Regents of the University of California, San Francisco, Vanderbilt University Medical Center, University of Washington. The program made 42 awards worth $524 million in that time.